ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,625Medicare Part D Prescriptions Filled, Including Refills

Rank: 102 out of 5176

$1.12M Total Retail Price of All Prescriptions

Rank: 195 out of 5176

617 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

3% of this provider’s 617 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

3% of this provider’s 16,211 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
AMLODIPINE BESYLATE 1,210 1,021 1 2
SIMVASTATIN 1,124 913 2 1
LOSARTAN-HYDROCHLOROTHIAZIDE 1,034 894 3 35
NIFEDIPINE ER 896 789 10 4 48
OMEPRAZOLE 586 466 5 3
LOSARTAN POTASSIUM 557 461 6 14
CRESTOR 544 461 7 15
METFORMIN HCL 514 417 8 7
CARVEDILOL 471 374 9 24
ENALAPRIL MALEATE 459 375 10 22
GLYBURIDE-METFORMIN HCL 372 279 R 11 76
FUROSEMIDE 365 311 12 8
METOPROLOL TARTRATE 319 286 13 6
ATORVASTATIN CALCIUM 290 246 14 9
LABETALOL HCL 274 226 15 114
GABAPENTIN 273 213 16 21
PRAVASTATIN SODIUM 249 195 17 23
HYDROCHLOROTHIAZIDE 244 216 18 10
METOPROLOL SUCCINATE 236 225 19 11
JANUVIA 235 166 20 25
CHLORTHALIDONE 212 147 21 122
LANTUS SOLOSTAR 212 125 21 70
ACARBOSE 208 172 23 223
SPIRONOLACTONE 199 132 24 88
TRAMADOL HCL 198 162 25 40
FLUTICASONE PROPIONATE 194 151 26 38
FOSINOPRIL SODIUM 188 175 27 105
VENTOLIN HFA 175 132 28 64
ALENDRONATE SODIUM 174 161 29 18
GLIPIZIDE XL 172 152 30 83
LEVOTHYROXINE SODIUM 165 151 31 4
GLIPIZIDE ER 163 145 32 117
TAMSULOSIN HCL 162 140 33 20
DONEPEZIL HCL 158 155 34 28
HYDRALAZINE HCL 157 133 35 73
CLOPIDOGREL 156 140 36 26
POTASSIUM CHLORIDE 149 115 37 34
JANUMET 148 131 38 77
ISOSORBIDE MONONITRATE ER 136 106 39 44
LISINOPRIL 124 96 40 5
WARFARIN SODIUM 121 97 41 13
LACTULOSE 119 74 42 87
LANTUS 118 85 43 66
ADVAIR DISKUS 117 86 44 32
PLAVIX 117 111 44 29
NEXIUM 104 93 46 16
DIOVAN HCT 103 92 47 39
AMLODIPINE BESYLATE-BENAZEPRIL 100 93 48 55
UNIFINE PENTIPS 94 60 49 261
ZETIA 93 80 50 68
LISINOPRIL-HYDROCHLOROTHIAZIDE 91 70 51 49
POLYETHYLENE GLYCOL 3350 89 67 52 74
MICARDIS HCT 87 77 53 180
DOXAZOSIN MESYLATE 87 73 53 103
DIOVAN 86 69 55 19
SINGULAIR 85 66 56 62
ATENOLOL-CHLORTHALIDONE 78 67 57 161
PROAIR HFA 73 58 58 60
ACTOS 73 68 58 85
ATENOLOL 70 57 60 12
CLONIDINE 68 45 61 295
FLOVENT HFA 66 66 62 203
GLYBURIDE 66 66 R 62 67
LOVASTATIN 63 53 64 46
NIFEDICAL XL 63 55 64 174
TRIAMTERENE-HCTZ 63 58 64 86
ZOLPIDEM TARTRATE 62 44 67 17
AMMONIUM LACTATE 61 37 68 91
AMITIZA 61 48 68 197
NAMENDA 61 61 68 47
PEN NEEDLE 60 45 71 144
INSULIN SYRINGE 59 36 72 137
FAMOTIDINE 58 46 73 58
MICARDIS 58 40 73 154
CALCITRIOL 57 57 75 261
CILOSTAZOL 56 56 76 206
ALCOHOL SWABS 56 51 76 115
IBUPROFEN 52 43 78 72
CITALOPRAM HBR 51 49 79 31
HUMALOG MIX 75-25 50 37 80 381
ONGLYZA 50 40 80 153
ALLOPURINOL 50 33 80 41
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 7, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.